Loading...
Loading...
India's meloxicam imports from BRAZIL total $516 across 1 shipments from 1 foreign suppliers. ZYDUS NIKKHO FARMACEUTICA LIMITEDA leads with $516 in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include ZYDUS HEALTHCARE LIMITED. This corridor reflects India's pharmaceutical import demand for meloxicam — a concentrated sourcing relationship with select suppliers from BRAZIL.

ZYDUS NIKKHO FARMACEUTICA LIMITEDA is the leading Meloxicam supplier from BRAZIL to India, with import value of $516 across 1 shipments. The top 5 suppliers — ZYDUS NIKKHO FARMACEUTICA LIMITEDA — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS NIKKHO FARMACEUTICA LIMITEDA | $516 | 1 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | ZYDUS HEALTHCARE LIMITED | $516 | 1 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Meloxicam suppliers from BRAZIL to India include ZYDUS NIKKHO FARMACEUTICA LIMITEDA. The leading supplier is ZYDUS NIKKHO FARMACEUTICA LIMITEDA with import value of $516 USD across 1 shipments. India imported Meloxicam worth $516 USD from BRAZIL in total across 1 shipments.
India imported Meloxicam worth $516 USD from BRAZIL across 1 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Meloxicam sourced from BRAZIL include ZYDUS HEALTHCARE LIMITED. The largest buyer is ZYDUS HEALTHCARE LIMITED with $516 in imports across 1 shipments.
The total value of Meloxicam imports from BRAZIL to India is $516 USD, across 1 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists